Breakthrough trial aims to slash TB treatment time in half
NCT ID NCT06441006
Summary
This international trial is testing whether shorter antibiotic regimens (13-24 weeks) can work as well as the current standard 24-week treatment for drug-resistant tuberculosis. Researchers will enroll 400 participants with specific drug-resistant TB strains to compare different treatment durations. The goal is to find the shortest effective treatment that maintains cure rates while reducing side effects and treatment burden.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS, PULMONARY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hanoi Lung Hospital
NOT_YET_RECRUITINGHanoi, Vietnam
Contact
Contact
-
Hospital Nacional Sergio E. Bernales
NOT_YET_RECRUITINGLima, Peru
Contact
Contact
-
Institute of Chest Diseases
NOT_YET_RECRUITINGKotri, Pakistan
Contact
-
Mulago National Referral Hospital
NOT_YET_RECRUITINGKampala, Uganda
Contact
-
National Center for Communicable Diseases
RECRUITINGUlaanbaatar, Mongolia
Contact
-
Policlínico SES
NOT_YET_RECRUITINGLima, Peru
Contact
Contact
Conditions
Explore the condition pages connected to this study.